Eggoz Raises USD 20 Mn Led by Gaja Capital to Fuel Market Expansion
Existing investors including IvyCap Ventures, Rebright Partners, Avaana Capital, Merisis Opportunities Fund, Nabventures, Blue Dot Capital, and Artek Chemicals also participated in the round.
You're reading Entrepreneur India, an international franchise of Entrepreneur Media.
Egg brand Eggoz has secured USD 20 million (approximately INR 167 crore) in a Series C funding round led by mid-market private equity firm Gaja Capital.
The round also saw continued support from existing investors including IvyCap Ventures, Rebright Partners, Avaana Capital, Merisis Opportunities Fund, NABVENTURES, Artek Chemicals, Blue Dot Capital, and notable angels such as Arvind Thakur and S. Ramadorai.
The fresh capital will be deployed to deepen Eggoz's footprint in its existing markets—Delhi NCR, Bengaluru, Hyderabad, Chennai, Mumbai, and Pune—while also expanding into East India. A portion of the funds will also go toward enhancing technology and supply chain infrastructure, ensuring hygienic and traceable egg distribution at scale.
Abhishek Negi, Co-founder and CEO of Eggoz, said, "We're excited to welcome Gaja Capital to the Eggoz family as we enter our next growth phase. At Eggoz, we're not just building a brand—we're redefining a category that reaches most Indian households. This capital will help us strengthen our presence, expand to new cities, and invest in technology and supply chain infrastructure."
Founded in 2017 by IIT Kharagpur alumni Abhishek Negi, Aditya Singh, and Uttam Kumar, Eggoz has built a strong consumer brand by focusing on clean, protein-rich, and hygienically produced eggs. The company offers its products online, especially through quick commerce platforms, and offline via organised retail chains. It currently operates in 11 major Indian cities and has rapidly scaled due to rising demand for safe, traceable protein sources.
Eggoz reported a 76% year-on-year revenue growth, hitting INR 130 crore in FY25, up from INR 74 crore the previous year. The company also achieved a peak annual recurring revenue (ARR) of INR 200 crore and EBITDA breakeven in Q4 FY25.
"Eggoz is solving a critical gap in India's protein ecosystem with a scalable, tech-first approach," said Gopal Jain, Managing Director at Gaja Capital. "Their vertically integrated model and brand strength uniquely position them for long-term leadership in food and nutrition."
Vikram Gupta, Founder of IvyCap Ventures, added, "With over 140 billion eggs produced in India annually, quality and traceability are critical. Eggoz is turning a fragmented category into a trusted consumer brand."
This latest funding round brings Eggoz's total capital raised to over USD 29 million. In 2022, it secured USD 8.8 million in Series B funding, led by IvyCap Ventures.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
34 minutes ago
- Forbes
Group Health Plan Funding: Alternative Considerations For Employers
Teah Corley is the founding principal and CEO of EmployerAdvocates. The landscape of employer-sponsored healthcare is rapidly evolving, with rising costs (registration required) driving the need for innovative funding alternatives. As a group health plan consultant for more than 20 years, I have seen many small and mid-sized employers—particularly those with fewer than 200 employees—think their only viable option is a fully insured plan through a national carrier. However, this approach often defers critical cost controls and financial advantages to the insurance companies. The Hidden Costs Of Fully Insured Plans In a fully insured model, employers relinquish control over cost containment and forfeit pharmaceutical rebate revenue. These rebates—paid by manufacturers to pharmacy benefit managers (PBMs) to secure approved drug list (formulary) placement—are retained by insurers rather than benefiting the employer's health plan. Additionally, fully insured employers often lack access to transparent claims data, making it difficult to analyze cost drivers or implement strategic savings initiatives. Ultimately, cost-containment options are limited, and premium increases leave employers with little recourse beyond plan design changes or cost-shifting to employees. Exploring Alternative Funding Models For many employers, the prospect of self-funding can be daunting due to concerns over cash flow and risk exposure. However, alternative strategies—such as level funding and group captive models—could offer a reasonable middle ground, enabling cost control and financial flexibility without assuming the full self-insured risk. Level funding mirrors the structure of a fully insured plan, but with a crucial distinction: When claims are lower than expected, employers can recoup surplus funds rather than losing them to an insurer. In a fully insured model, this excess funding is retained by the insurance carrier. The level-funded model provides greater financial predictability while offering the potential for cost savings. For employers seeking even greater control, group captive funding allows employers to share risk through risk pools spread among multiple employers. Under this model, each participant self-funds claims up to a predetermined stop-loss threshold, beyond which costs are covered by a shared risk layer and, ultimately, a reinsurance policy. This structure allows smaller businesses to leverage the benefits traditionally reserved for large self-funded employers, such as lower pharmacy spend—in my experience, employers often see a 13% to 15% reduction in drug costs when transitioning from a fully insured to a self-funded model with full rebate pass-through. This number is also consistent with what we hear from our peers across the country. Other benefits may include: • Full transparency into claims data for strategic cost management • Retention of pharmaceutical rebates to offset expenses • Reduced administrative costs and ability to plug-and-play best-in-class vendors • Greater control as self-funded employers control their own custom plan designs and implement custom cost-containment solutions Employers also have the option of advanced funding models whereby a plan's full three-year projected liability, plus a buffer (often 15% to 25%), is underwritten and funded in advance. This three-year advanced funding is provided via a private capital raise with a capital partner that retains the risk with the employer leveraging the interest earned on a large sum over three years. This model creates a static, reliable budget and fixed monthly contribution over 36 months. The corpus is held in a special purpose entity trust and the health plan's monthly fixed costs and claims are paid from the trust. The trust itself carries the debt at a 102% collateralization level. This advanced funding strategy can be wrapped around and co-exist with a fully insured, level-funded or self-funded model to create stability and predictability over an extended period beyond the traditional one-year policy cycle. Making The Right Choice For Company Needs I've noticed employers that employ 50 to 200 people are the most vulnerable to the misconception that the only option for an employer this size is to fully insure its health plan risk through an insurance carrier. Historically, selecting a fully insured plan was the only option for employers in this size range. Captive models that allow employers to share a layer of risk at the stop-loss level have gained momentum in recent years as a mechanism for allowing smaller employers to self-fund a portion of health plan risk to gain greater control over cost containment. Many employers operate under the misconception that self-funding exposes the plan to open-ended risk. To the contrary, self-funded plans that incorporate a layer of stop-loss insurance or a shared captive layer of risk have a known maximum liability, very similar to fully insured plans. The key difference is that self-funded plans have access to greater transparency, control and cost-containment flexibility. When it comes to the risks that employers need to know about to make fully informed decisions, it's important for employers to fully understand the policy terms and limitations. For example, a self-funded strategy with stop-loss or a captive funding strategy will include a stop-loss insurance policy to protect the employer from upside risk. Each policy type has a maximum liability, but may also contain limitations or exclusions. It's also important for employers to fully understand the "attachment point" or the maximum liability that the employer will be responsible for versus what liability the stop-loss or captive will assume. Reading and understanding the policy terms and exclusions to fully understand the maximum liability can help employers better mitigate risk exposure. The Future Of Employer-Sponsored Healthcare As healthcare costs continue to rise, employers can explore innovative funding strategies to maintain affordability and control. Level funding and captive models may present compelling alternatives that help balance risk, transparency and financial efficiency. For forward-thinking businesses, these approaches could offer a pathway to sustainable, cost-effective healthcare solutions—without sacrificing the quality of employee benefits or financial stability. Employers may want to request a funding analysis from their broker or consultant to compare and contrast the financial implications, pros and cons of each funding model to make fully informed decisions. The information provided here is not investment, tax, or financial advice. You should consult with a licensed professional for advice concerning your specific situation. Forbes Business Council is the foremost growth and networking organization for business owners and leaders. Do I qualify?
Entrepreneur
36 minutes ago
- Entrepreneur
From Deal Sourcing to Exits: The AI Advantage in Venture Capital
In India, firms are doubling down on tech-led diligence and proprietary data-driven strategies. As AI adoption deepens, it promises to sharpen competitive edges, even as challenges around infrastructure and talent persist. Opinions expressed by Entrepreneur contributors are their own. You're reading Entrepreneur India, an international franchise of Entrepreneur Media. Artificial Intelligence is fast becoming the next big disruptor in the venture capital landscape, not just as an investment theme but as a transformative internal tool. In India, firms are doubling down on tech-led diligence and proprietary data-driven strategies. As AI adoption deepens, it promises to sharpen competitive edges, even as challenges around infrastructure and talent persist. According to a recent report by Gitnux, 42 per cent of VC firms globally use AI for deal sourcing, while 68 per cent of the firms believe that this technology will significantly improve investment decision accuracy. The report further stated that in deal sourcing and market research, proprietary deal-scanning tools and analytics platforms are adopted by 75 per cent of top-tier VC firms worldwide. When it comes to due diligence, NLP-driven sentiment analysis is helping as much as 50 per cent of VCs assess market and founder cues in real-time. VCs also reported a 70 per cent improvement in portfolio-related operational efficiency using AI-backed dashboards and KPIs, according to data from Gitnux. Rahul Agarwalla, Managing Partner, SenseAI, feels that what used to take weeks now only takes hours. "AI has redefined the front end of our venture workflow, from deal sourcing to diligence, giving us unprecedented scale, speed, and precision. At SenseAI, our proprietary engine surfaces technical founders months before they raise, using a live signal graph of research papers, product launches, and social media activity. We run thematic market scans, generate automated investment briefs, and close transactions faster with NLP-powered agents," said Agarwalla. AI is poised to be the next VC game-changer by enabling faster, data-driven decision making, with the technology helping firms filter a large number of startups more efficiently and spot leads earlier. AI can also help in faster, data-driven decision making by enabling NLP analyses of customer sentiment, founder profiles, and competitiveness. The new-age technology can also help create value through talent and tech advisory a with commitments to "AI-first" theses and tech depth help VCs distinguish themselves from peers. AI is proving to be more than just a vertical for investing, but is also reshaping the VC toolkit in India. As the adoption of this new-age technology accelerates, one can expect VC firms to increase hiring of AI talent, build proprietary analytics and deal-screening systems, and bolster infrastructure with partnerships and advocacy around AI. While promising, challenges exist around GPU shortages and limited domestic LLMs that slow down scalable innovation. VC firms are still in the initial stages of the race to hire AI/ML professionals for internal processes. Although AI helps us do things faster, venture is still a deeply human craft, and "Models can't assess founder resilience, ethical integrity, or long-term vision, only repeated human interaction can. AI gives us leverage; human judgment gives us conviction." "The firms that get this balance right will define the next decade of venture capital. Venture capital is paid to underwrite non-linear futures. Deciding whether a novel idea can become a category-defining company is a deeply human endeavor rooted in taste, contrarian insight, imagination, and pattern-breaks that AI cannot model or predict," said Agarwalla. While challenges remain, the fusion of national initiatives such as IndiaAI and VC-driven AI integration signals a transformative shift in how capital is deployed and value is generated. India's AI-powered VC evolution may very well define the next wave of startup success and potentially global exit narratives.
Associated Press
39 minutes ago
- Associated Press
HCLTech and OpenAI Collaborate to Drive Enterprise-Scale AI Adoption
NEW YORK & NOIDA, India--(BUSINESS WIRE)--Jun 30, 2025-- HCLTech, a leading global technology company, today announced a multi-year strategic collaboration with OpenAI, a leading AI research and deployment company, to drive large-scale enterprise AI transformation as one of the first strategic services partners to OpenAI. HCLTech's deep industry knowledge and AI Engineering expertise lay the foundation for scalable AI innovation with OpenAI. This collaboration will enable HCLTech's clients to leverage OpenAI's industry-leading AI products portfolio alongside HCLTech's foundational and applied AI offerings for rapid and scaled GenAI deployment. Additionally, HCLTech will embed OpenAI's industry-leading models and solutions across its industry-focused offerings, capabilities and proprietary platforms, including AI Force, AI Foundry, AI Engineering and industry-specific AI accelerators. This deep integration will help its clients modernize business processes, enhance customer and employee experiences and unlock growth opportunities, covering the full AI lifecycle, from AI readiness assessments and integration to enterprise-scale adoption, governance and change management. HCLTech will roll out ChatGPT Enterprise and OpenAI APIs internally, empowering its employees with secure, enterprise-grade generative AI tools. Vijay Guntur, Global Chief Technology Officer (CTO) and Head of Ecosystems at HCLTech, said, 'We are honored to work with OpenAI, the global leader in generative AI foundation models. This collaboration underscores our commitment to empowering Global 2000 enterprises with transformative AI solutions. It reaffirms HCLTech's robust engineering heritage and aligns with OpenAI's spirit of innovation. Together, we are driving a new era of AI-powered transformation across our offerings and operations at a global scale.' Giancarlo 'GC' Lionetti, Chief Commercial Officer at OpenAI, said, 'HCLTech's deep industry knowledge and AI engineering expertise sets the stage for scalable AI innovation. As one of the first system integration companies to integrate OpenAI to improve efficiency and enhance customer experiences, they're accelerating productivity and setting a new standard for how industries can transform using generative AI.' About HCLTech HCLTech is a global technology company, home to more than 223,000 people across 60 countries, delivering industry-leading capabilities centered around digital, engineering, cloud and AI, powered by a broad portfolio of technology services and products. We work with clients across all major verticals, providing industry solutions for Financial Services, Manufacturing, Life Sciences and Healthcare, High Tech, Semiconductor, Telecom and Media, Retail and CPG and Public Services. Consolidated revenues as of 12 months ending March 2025 totaled $13.8 billion. To learn how we can supercharge progress for you, visit View source version on CONTACT: For more information, please contact:Meredith Bucaro, Americas [email protected] Ghudial, EMEA [email protected] Galvin, APAC [email protected] Shukla, India [email protected] KEYWORD: AUSTRALIA/OCEANIA IRELAND AUSTRALIA SOUTHEAST ASIA NORTH AMERICA UNITED STATES SINGAPORE ASIA PACIFIC UNITED KINGDOM EUROPE INDIA NEW YORK INDUSTRY KEYWORD: INTERNET DATA MANAGEMENT TECHNOLOGY ARTIFICIAL INTELLIGENCE SOFTWARE SOURCE: HCLTech Copyright Business Wire 2025. PUB: 06/30/2025 07:03 AM/DISC: 06/30/2025 07:03 AM
